Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier (original) (raw)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

Ehsan Razeghian

Cell Communication and Signaling, 2022

View PDFchevron_right

Immune checkpoints in the tumor microenvironment

Neda Khosravi

Seminars in Cancer Biology, 2019

View PDFchevron_right

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired

Hany Marei

Cancer Cell International

View PDFchevron_right

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

Yufang Shi

Journal of hematology & oncology, 2018

View PDFchevron_right

A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy

Arjun Mittra, Cancer Drug Resistance

Cancer Drug Resistance, 2020

View PDFchevron_right

Increasing cure rates of solid tumors by immune checkpoint inhibitors

Tianhong Li

Experimental hematology & oncology, 2023

View PDFchevron_right

Immune Checkpoint Blockade: The New Frontier in Cancer Treatment

daniel george

Targeted oncology, 2018

View PDFchevron_right

Immune Checkpoint Inhibitors in Cancer Therapy

Mohammad amin Kashani

Current Oncology

View PDFchevron_right

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Rachael Zemek

Frontiers in Immunology, 2020

View PDFchevron_right

Immune Checkpoints are Important Therapeutic Targets in Cancer Immunotherapy

Shyamali Mukherjee

Cancer Science & Research, 2021

View PDFchevron_right

Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation

Evelyn Hutterer

View PDFchevron_right

Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung Cancer

Famke Schneiders

American Society of Clinical Oncology Educational Book

View PDFchevron_right

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma

Viktor Umansky

International Journal of Molecular Sciences

View PDFchevron_right

Host response to immune checkpoint inhibitors contributes to tumor aggressiveness

Bob Krast

Journal for ImmunoTherapy of Cancer

View PDFchevron_right

Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies

Marilina García Aranda

Drug Resistance Updates, 2020

View PDFchevron_right

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies

Esosa Ukponmwan

Annals of Surgical Oncology, 2018

View PDFchevron_right

Immune checkpoints inhibitors in cancer therapy-current status and future prospects

Rhishika Dutta, Imad Khan, Meghana Sai, Nadeem Siddiqui

International journal of health sciences

View PDFchevron_right

Immune and Cell Cycle Checkpoint Inhibitors for Cancer Immunotherapy

Erlinda Gordon

Advances in Precision Medicine Oncology, 2021

View PDFchevron_right

Immune Checkpoints in Cancers: From Signaling to the Clinic

Robert Ballotti

Cancers, 2021

View PDFchevron_right

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

Marco Merlano

Cancer Treatment Reviews

View PDFchevron_right

Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise

Brian Bird

Diagnostics, 2022

View PDFchevron_right

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms

Yoshinobu Koguchi

Frontiers in Immunology

View PDFchevron_right

Targeting the Tumor Microenvironment to Overcome Resistance to Therapy

Myron Szewczuk

Resistance to targeted anti-cancer therapeutics, 2019

View PDFchevron_right

Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

Gboyega Adebami

Global Journal of Cancer Therapy

View PDFchevron_right

Advancing cancer immunotherapy: a vision for the field

Noel de Miranda

Genome Medicine

View PDFchevron_right

New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials

Yitao Mao

International Journal of Biological Sciences

View PDFchevron_right

Immune checkpoint inhibitors: An innovation in immunotherapy for the treatment and management of patients with cancer

Mary Kate Kasler

Asia-Pacific Journal of Oncology Nursing, 2017

View PDFchevron_right

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

Alessandra Cesano

Cancer Immunology Research, 2022

View PDFchevron_right